Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v6.3)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-9

Query Trace: Thrombosis and meta-analysis and JAK2[orginal query]

Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2(V617F) mutations and laboratory findings: a meta-analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Feb . Saki N, Shirzad R, Rahim F, Saki Malehi Similar articles in PubMed
Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis. Annals of hematology 2016 Sep . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq Similar articles in PubMed
Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis. Annals of hematology 2016 Jul . Pei Yu-Qing, Wu Yue, Wang Fei, Cui W Similar articles in PubMed
Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis. Clinical lymphoma, myeloma & leukemia 2016 Feb . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq Similar articles in PubMed
The JAK2 46/1 haplotype (GGCC) in myeloproliferative neoplasms and splanchnic vein thrombosis: a pooled analysis of 26 observational studies. Annals of hematology 2014 Nov 93 (11): 1845-52. Li Sheng-Li, Zhang Pei-Jin, Sun Gui-Xiang, Lu Zhao-J Similar articles in PubMed
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood 2009 May 113 (22): 5617-23. Dentali Francesco, Squizzato Alessandro, Brivio Lorenza, Appio Lorena, Campiotti Leonardo, Crowther Mark, Grandi Anna Maria, Ageno Walt Similar articles in PubMed
JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease. Journal of thrombosis and haemostasis : JTH 2009 Apr 7 (4): 722-5. Dentali F, Squizzato A, Appio L, Brivio L, Ageno Similar articles in PubMed
Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review. Thrombosis research 2009 Mar . Lussana F, Caberlon S, Pagani C, Kamphuisen PW, Büller HR, Cattaneo M Similar articles in PubMed
Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia. Leukemia research 2009 Jan 33 (1): 67-73. Dahabreh Issa J, Zoi Katerina, Giannouli Stavroula, Zoi Christine, Loukopoulos Dimitrios, Voulgarelis Micha Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Mar 16, 2019
Page last updated:Aug 12, 2020
Content source:

TOP